US$ 20.07
first large study of glp-1 receptor agonists during pregnancy Continuing Glucagon-Like Peptide-1 Into the Trimester and Pregnancy Outcomes: A Target Trial Emulation Using Claims Information: Annals of Internal Medicine: Vol 0, No 0 PDF) GLP-1 Receptor Agonist Use
Description
The internal solution for whole-cell and cell-attached recordings consisted of 126 mM K-gluconate, 10 mM NaCl, 1 mM MgCl 2 , 10 mM EGTA, 10 mM HEPES, 2 mM NaATP, and 0.1 mM Na 2 GTP, adjusted to pH 7.3 with KOH, with an osmolarity of 295300 mOsm

Lancet 387 , 679690 (2016)

American Kidney Fund
Patients with pre-existing vascular risk factorsincluding hypertension, dyslipidemia, and diabetic retinopathymay be particularly susceptible

doi: 10.1016/S0140-6736(21)02188-7 74 BattelinoTBergenstalRMRodrguezAFernndez LandLBrayRTongZet al
